市场调查报告书
商品编码
1470747
癌症资讯系统市场:按解决方案、服务、应用程式和最终用户划分 - 全球预测 2024-2030Oncology Information Systems Market by Solutions, Service, Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年癌症资讯系统市场规模为88.5亿美元,预计2024年将达到95.5亿美元,2030年将达到156.7亿美元,复合年增长率为8.50%。
癌症资讯系统 (OIS) 是专门专用平台,旨在管理与癌症治疗相关的复杂资料和工作流程。癌症资讯系统为临床医生、肿瘤学家和医疗保健提供者提供了一套全面的工具,可以有效地规划、管理和监测从诊断到生存的整个范围内的癌症护理。癌症发病率的增加、对综合卫生系统的重视以及对个人化医疗的需求不断增加正在导致医疗保健基础设施的扩张和市场采用率的提高。然而,对储存和管理患者记录时的资料安全和隐私的担忧可能会阻碍市场成长。然而,用于肿瘤学专家之间的远端存取和即时协作的基于云端基础的解决方案的加强,以及用于病人参与和即时监测的行动应用程式的开拓,为预期的市场成长提供了潜在的机会。
主要市场统计 | |
---|---|
基准年[2023] | 88.5亿美元 |
预测年份 [2024] | 95.5亿美元 |
预测年份 [2030] | 156.7亿美元 |
复合年增长率(%) | 8.50% |
解决方案化疗资讯系统的使用激增以减少用药错误
先进的可视化和影像分析解决方案提供用于详细解剖评估的高解析度影像和工具,用于需要精确诊断成像的复杂病例,例如脑肿瘤和胰腺癌,这对于肿瘤识别和表征至关重要。近距离放射治疗计划系统是用于计划内部放射治疗的专用软体,同时保留周围的健康组织,这对于可以透过近距离放射治疗治疗的癌症(例如子宫颈癌和前列腺癌)至关重要。目标进行精确治疗。临床决策支援系统可帮助医生根据患者病历和科学指南等分析资料做出决策,并整合到所有肿瘤学实践中,以确保使用基于证据的治疗。临床整合解决方案使各种肿瘤相关软体系统能够有效地通讯和交换资料,对于使用多个系统的医疗保健提供者至关重要。实验室资讯系统是管理临床实验室业务的数位平台,对于经常进行临床测试的癌症中心至关重要。肿瘤电子健康记录(EHR) 系统旨在满足肿瘤治疗和患者管理的复杂需求,对于每个肿瘤实践的全面患者记录管理至关重要。影像储存和通讯系统 (PACS) 和供应商中立存檔 (VNA) 系统可以在医疗保健系统之间安全地储存和共用医学影像,对于放射学和多中心实践至关重要。人口健康管理是一种工具,旨在分析和管理跨人群的患者资料,以大规模改善医疗保健结果。辐射剂量管理 一种解决方案,旨在追踪并最大程度地减少放射治疗诊所诊断和治疗期间患者受到的辐射暴露。管理医院和诊所放射科的工作流程和病患资料的放射资讯系统。放射治疗计划系统是先进的软体,为放射肿瘤科医师提供规划和模拟放射治疗的工具,对于放射治疗设施至关重要。治疗管理系统和医学影像分析系统涵盖用于管理整个治疗过程(从诊断到治疗后追踪)的各种系统,并包括用于医学诊断的高级影像分析。治疗计划系统将多种治疗方式和时间表整合为一个连贯的计划,用于计划复杂的癌症治疗,并且是提供多模式癌症治疗的设施所必需的。
应用癌症资讯系统在肿瘤外科的高阶应用
肿瘤内科使用化疗、荷尔蒙疗法、生物疗法和标靶治疗来治疗癌症。肿瘤医学领域的 OIS 以患者管理系统为中心,该系统为管理患者病历、用药订单、治疗计划和追踪患者结果提供全面的解决方案。它们通常还包括临床决策支援系统,以帮助肿瘤学家根据实证通讯协定选择合适的化疗方案。放射肿瘤学专注于消除癌细胞的放射线治疗。用于放射肿瘤学的 OIS 通常包括治疗计画系统、剂量管理、影像导航放射治疗(IGRT) 系统以及控制放射输送的设备参数。此系统可确保精确的目标照射,同时最大限度地减少对周围健康组织的损害。肿瘤外科涉及手术切除癌性肿瘤,通常辅以其他治疗。在 OIS 中,肿瘤外科应用专注于术前计划、手术导引、术后护理和手术干预记录。这些应用程式可以与图片存檔和通讯系统 (PACS) 以及电子健康记录(EHR) 集成,以改善临床工作流程。肿瘤外科需要仔细的治疗计划和协调。 OIS 有助于安排手术、追踪患者復健情况并管理后续护理,这对于患者的持续护理非常有价值。
区域洞察
在美洲,癌症发生率上升、技术进步以及支持癌症研究的医疗改革的实施推动了对 OIS 的需求。先进的医疗基础设施和较高的人均医疗费用造就了良好的市场环境。在加拿大,政府的措施和对癌症研究的资助正在推动 OIS 的采用。欧盟 (EU) 国家因其完善的医疗保健系统和积极参与癌症研究而对 OIS 表现出很高的需求。 《一般资料保护规范》(GDPR) 也影响 OIS 的开发和实施,以确保病患资料的安全和隐私。该地区普及对个人化医疗和综合护理模式进行了大量投资。中东和非洲的 OIS 市场是一个新兴市场,由于医疗保健支出的增加和基础设施的发展,中东地区的采用速度正在加快。在非洲,由于资源限制,市场成长正在放缓,但经济和医疗保健的逐步改善提供了长期商机。在亚太地区,特别是在中国和日本,政府在癌症控制、增加医疗保健支出和人口老化方面的倡议是推动 OIS 市场的关键因素。同时,由于癌症发病率上升和医疗基础设施不断改善,印度是一个快速成长的市场。
FPNV定位矩阵
FPNV定位矩阵对于评估癌症资讯系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对癌症资讯系统市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.癌症资讯系统市场的市场规模与预测是多少?
2.在癌症资讯系统市场的预测期间内,有哪些产品、细分市场、应用程式和领域需要考虑投资?
3.癌症资讯系统市场的技术趋势和法规结构是什么?
4.癌症资讯系统市场主要厂商的市场占有率是多少?
5.进入癌症资讯系统市场的适当型态和策略手段是什么?
[193 Pages Report] The Oncology Information Systems Market size was estimated at USD 8.85 billion in 2023 and expected to reach USD 9.55 billion in 2024, at a CAGR 8.50% to reach USD 15.67 billion by 2030.
Oncology Information Systems (OIS) are integrated, specialized platforms designed to manage the complex data and workflow processes associated with cancer treatment. Oncology Information systems provide a comprehensive suite of tools that assist clinicians, oncologists, and healthcare providers in efficiently planning, managing, and monitoring the entire cancer care continuum from diagnosis to survivorship. The growing prevalence of cancer, focus on integrated healthcare systems, and rising demand for personalized medicine expansion of healthcare infrastructure increase market adoption. However, concerns regarding data security and privacy in storing and managing patient records may impede market growth. Nevertheless, enhanced cloud-based solutions for remote access and real-time collaboration among oncology specialists and the development of mobile applications for patient engagement and real-time monitoring are expected to create potential opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.85 billion |
Estimated Year [2024] | USD 9.55 billion |
Forecast Year [2030] | USD 15.67 billion |
CAGR (%) | 8.50% |
Solutions: Burgeoning usage of chemotherapy information systems to reduce medication errors
Advanced Visualization & Image Analysis Solutions provide high-resolution images and tools for detailed anatomical assessments, crucial in identifying and characterizing tumors used in complex cases requiring precise imaging, such as brain or pancreatic cancer. Brachytherapy Treatment Planning Systems is software specializing in the planning of internal radiotherapy, allowing precision in the delivery of treatment to cancerous tissues while sparing surrounding healthy tissue, which is essential for cancers treatable with brachytherapy, such as cervical or prostate cancer. Clinical Decision Support Systems assist physicians in making decisions based on analytical data, such as patient history and scientific guidelines, and are used for all oncology practices to ensure evidence-based treatment. Clinical Integration solutions ensure that various oncology-related software systems can communicate and exchange data efficiently, which is essential for healthcare providers using multiple systems. Laboratory Information Systems is a digital platform that manages medical laboratory operations, crucial for cancer centers that conduct frequent lab tests. Oncology Electronic Medical Record (EHR) systems are designed to address the complex needs of oncology treatments and patient management, and they are integral for all oncology practices for comprehensive patient record-keeping. Picture Archiving & Communication System (PACS) & Vendor Neutral Archive (VNA) systems store and allow secure sharing of medical images across healthcare systems and are vital for radiology departments and multi-site practices. Population Health Management is a tool designed to analyze and manage patient data across a population to improve healthcare outcomes on a large scale. Radiation Dose Management Solutions aimed at tracking and minimizing radiation exposure to patients during diagnostic and therapeutic procedures for practices offering radiation therapy. Radiology Information Systems for managing workflow and patient data in the radiology department of a hospital or a clinic. Radiotherapy Treatment Planning Systems are advanced software that provides radiation oncologists with tools to plan and simulate radiotherapy treatment, essential for centers providing radiotherapy. Treatment Management Systems & Medical Image Analysis Systems encompass a range of systems used to manage the entire treatment process, from diagnosis through post-treatment follow-up, and include sophisticated image analysis for medical diagnosis. Treatment Planning Systems are used for planning complex cancer treatments, integrating multiple treatment modalities and schedules into a coherent plan, and are necessary for facilities that offer multi-modal cancer treatments.
Application: Evolving usage of oncology information systems for surgical oncology
Medical Oncology incorporates the use of chemotherapy, hormonal therapy, biological therapy, and targeted therapy to treat cancer. OIS in medical oncology is centered around the patient management system, providing a comprehensive solution for managing the patient's medical history, medication orders, treatment scheduling, and tracking of patient outcomes. It often includes clinical decision support systems to help oncologists choose the proper chemotherapy regimens based on evidence-based protocols. Radiation Oncology focuses on the administration of radiation therapy to eliminate cancer cells. OIS for radiation oncology typically features treatment planning systems, dose management, image-guided radiation therapy (IGRT) systems, and machine parameters controlling radiation delivery. The system ensures precise targeting, minimizing damage to surrounding healthy tissues. Surgical Oncology involves the surgical excision of cancerous tumors and is often complemented by other treatments. Within OIS, surgical oncology applications focus on preoperative planning, operative navigation, postoperative care, and the documentation of surgical interventions. They may integrate with picture archiving and communication systems (PACS) and electronic health records (EHR) for improved clinical workflows. Surgical oncology requires detailed planning and coordination of care. OIS aids in scheduling surgeries, tracking patient recovery, and managing follow-up care, which is highly beneficial for a patient's continuum of care.
Regional Insights
In the Americas, the demand for Oncology Information Systems (OIS) is driven by the increasing incidence of cancer, technological advancements, and the implementation of healthcare reforms supporting oncology research. Advanced healthcare infrastructure and high per capita healthcare expenditure contribute to a favorable market environment. In Canada, government initiatives and funding for cancer research support the adoption of OIS. European Union (EU) countries exhibit a high demand for OIS due to their well-established healthcare systems and active participation in cancer research. The General Data Protection Regulation (GDPR) has also influenced the development and implementation of OIS to ensure patient data security and privacy. Significant investments in personalized medicine and integrated care models are prevalent in the region. The OIS market in the Middle East and Africa is emerging, with the Middle East showing faster adoption due to increasing healthcare expenditure and infrastructure development. In Africa, the market growth is slower due to resource constraints; however, it presents a long-term opportunity with gradual economic and healthcare improvements. In the Asia-Pacific region, especially in China and Japan, government initiatives for cancer control, increasing healthcare expenditure, and the aging population are significant factors driving the OIS market. India, on the other hand, presents a rapidly growing market due to the rising incidence of cancer and ongoing improvements in healthcare infrastructure.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Oncology Information Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oncology Information Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Oncology Information Systems Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Data Systems, Advanced Data Systems Corporation, Allscripts Healthcare Solutions, Inc., Altai AS, CureMD.com, Inc., DOSIsoft SA, Elekta AB, EndoSoft LLC, Epic Systems Corporation, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., International Business Machines Corporation, Karkinos Healthcare, Koninklijke Philips N.V., McKesson Corporation, MICA Information Systems, Inc., Oracle Corporation, RaySearch Laboratories, Siemens Healthineers AG, Sify Technologies, UnitedHealth Group Inc., and ViewRay Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Oncology Information Systems Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oncology Information Systems Market?
3. What are the technology trends and regulatory frameworks in the Oncology Information Systems Market?
4. What is the market share of the leading vendors in the Oncology Information Systems Market?
5. Which modes and strategic moves are suitable for entering the Oncology Information Systems Market?